Answers are grounded in this paper and cite their sources.
A review highlights fosfomycin's effectiveness against multidrug-resistant Acinetobacter infections in Türkiye, suggesting a critical treatment alternative.
Multi-drug resistant (MDR) Acinetobacter baumannii is now a major pathogen responsible for morbidity and mortality in intensive care units. Fosfomycin has been used as a "salvage" therapy in these cases. Resistance to colistin, which was frequently used in the treatment of Acinetobacter baumannii infections in previous years, has pushed the use of fosfomycin to the forefront of research. The purpose of this review was to draw attention to the potential risk of MDR Acinetobacter infections in Türkiye.
No takes yet. Share an insight, caveat, or question.
Serpil Oğuz Mızrakçı (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: